首页> 外文期刊>Analytical methods >Plasmonic nanograting enhanced fluorescence for protein microarray analysis of carcinoembryonic antigen (CEA)
【24h】

Plasmonic nanograting enhanced fluorescence for protein microarray analysis of carcinoembryonic antigen (CEA)

机译:等离子纳米光栅增强荧光用于癌胚抗原(CEA)的蛋白质微阵列分析

获取原文
           

摘要

The low sensitivity of protein microarrays has limited the wide application in diagnostics and high-throughput proteomic analysis. We present, for the first time, the exploration of protein microarray analysis on nanostructured plasmonic gold nanograting that showed a 10-fold fluorescence enhancement. The as-fabricated plasmonic protein microarray showed a limit of detection (LOD) of 0.36 ng mL?1 with the dynamic detection range of 1 ng mL?1 to 100 μg mL?1 for detecting the cancer biomarker of carcinoembryonic antigen (CEA). The LOD determined in this study is one order lower than that of the commercial planar glass substrates, which is attributed to the surface plasmon field enhanced fluorescence (SPFS) from the plasmonic coupling. The highly sensitive and wide dynamic detection range of plasmonic microarrays presents new opportunities in proteomic applications and diagnostics research.
机译:蛋白质微阵列的低灵敏度限制了其在诊断和高通量蛋白质组学分析中的广泛应用。我们目前,第一次,蛋白质微阵列分析探索显示出10倍的荧光增强的纳米结构的等离激元金纳米光栅。制成的等离激元蛋白质微阵列显示的检出限(LOD)为0.36 ng mL?1,动态检测范围为1 ng mL?1至100μgmL?1,用于检测癌胚抗原(CEA)的癌症生物标志物。在这项研究中确定的LOD比商用平面玻璃基板的LOD低一个数量级,这归因于等离子体耦合产生的表面等离子体场增强荧光(SPFS)。等离子体芯片的高灵敏度和宽动态检测范围为蛋白质组学应用和诊断研究提供了新的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号